NephroGenex
Drug-development company focusing on kidney disease and progression of diabetic kidney disease.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | $5.5m | Post IPO Equity | |
| Total Funding | 000k | ||
Related Content
Nephrogenex operates as a legitimate online pharmacy, providing a comprehensive range of pharmaceutical products, including medications, herbal supplements, medical cosmetics, and medical equipment. The company caters to customers who prefer the convenience of ordering online rather than visiting physical pharmacies. Nephrogenex serves a global clientele, offering a user-friendly online catalog that is categorized for easy navigation and includes a search function by letter or name. The business model focuses on providing high-quality, original products and additional services such as reserving goods, assisting in finding medicines, and offering medical equipment not currently available. Revenue is generated through the sale of these pharmaceutical products and services. The company emphasizes customer satisfaction and cost-saving options, which contribute to its positive reviews and repeat business.
Keywords: online pharmacy, medications, supplements, medical equipment, global clientele, cost-saving, original products, customer satisfaction, convenient ordering, comprehensive catalog.